Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study AL Oblak, PB Lin, KP Kotredes, RS Pandey, D Garceau, HM Williams, ... Frontiers in aging neuroscience 13, 713726, 2021 | 167 | 2021 |
Chemogenetic manipulations of ventral tegmental area dopamine neurons reveal multifaceted roles in cocaine abuse SV Mahler, ZD Brodnik, BM Cox, WC Buchta, BS Bentzley, J Quintanilla, ... Journal of Neuroscience 39 (3), 503-518, 2019 | 93 | 2019 |
Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder JW Young, ZA Cope, B Romoli, E Schrurs, A Joosen, J van Enkhuizen, ... Neuropsychopharmacology 43 (8), 1721-1731, 2018 | 59 | 2018 |
Premature responses in the five-choice serial reaction time task reflect rodents’ temporal strategies: evidence from no-light and pharmacological challenges ZA Cope, AL Halberstadt, J van Enkhuizen, AD Flynn, M Breier, ... Psychopharmacology 233, 3513-3525, 2016 | 56 | 2016 |
Modeling neurodevelopmental cognitive deficits in tasks with cross‐species translational validity ZA Cope, SB Powell, JW Young Genes, Brain and Behavior 15 (1), 27-44, 2016 | 43 | 2016 |
Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model RW Brown, AM Maple, MK Perna, AB Sheppard, ZA Cope, RM Kostrzewa Developmental neuroscience 34 (2-3), 140-151, 2012 | 42 | 2012 |
DREADD-mediated modulation of locus coeruleus inputs to mPFC improves strategy set-shifting ZA Cope, EM Vazey, SB Floresco, GSA Jones Neurobiology of learning and memory 161, 1-11, 2019 | 40 | 2019 |
Amphetamine increases activity but not exploration in humans and mice A Minassian, JW Young, ZA Cope, BL Henry, MA Geyer, W Perry Psychopharmacology 233, 225-233, 2016 | 36 | 2016 |
Chronic methamphetamine self-administration alters cognitive flexibility in male rats BM Cox, ZA Cope, A Parsegian, SB Floresco, G Aston-Jones, RE See Psychopharmacology 233, 2319-2327, 2016 | 35 | 2016 |
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species ZA Cope, A Minassian, D Kreitner, DA MacQueen, M Milienne-Petiot, ... Neuropharmacology 125, 254-262, 2017 | 28 | 2017 |
Oxytocin improves probabilistic reversal learning but not effortful motivation in Brown Norway rats BZ Roberts, JW Young, YV He, ZA Cope, PD Shilling, D Feifel Neuropharmacology 150, 15-26, 2019 | 27 | 2019 |
Uncovering disease mechanisms in a novel mouse model expressing humanized APOEε4 and Trem2* R47H KP Kotredes, A Oblak, RS Pandey, PBC Lin, D Garceau, H Williams, ... Frontiers in Aging Neuroscience 13, 735524, 2021 | 26 | 2021 |
The five‐choice continuous performance task (5C‐CPT): a cross‐species relevant paradigm for assessment of vigilance and response inhibition in rodents ZA Cope, JW Young Current protocols in neuroscience 78 (1), 9.56. 1-9.56. 18, 2017 | 26 | 2017 |
Dopamine transporter knockdown mice in the behavioral pattern monitor: a robust, reproducible model for mania-relevant behaviors MA Kwiatkowski, G Hellemann, CA Sugar, ZA Cope, A Minassian, ... Pharmacology Biochemistry and Behavior 178, 42-50, 2019 | 24 | 2019 |
Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood ZA Cope, KN Huggins, AB Sheppard, DM Noel, DS Roane, RW Brown Synapse 64 (4), 289-300, 2010 | 23 | 2010 |
Nicotine sensitization in adult male and female rats quinpirole-primed as neonates MK Perna, ZA Cope, AM Maple, ID Longacre, JA Correll, RW Brown Psychopharmacology 199, 67-75, 2008 | 18 | 2008 |
Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes. B Sheppard, J Lehmann, ZA Cope, RW Brown Behavioral neuroscience 123 (6), 1296, 2009 | 17 | 2009 |
Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study. Front Aging Neurosci 13: 713726 AL Oblak, PB Lin, KP Kotredes, RS Pandey, D Garceau, HM Williams, ... | 11 | 2021 |
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study KD Onos, SK Quinney, DR Jones, AR Masters, R Pandey, KJ Keezer, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 8 | 2022 |
Converging evidence that short-active photoperiod increases acetylcholine signaling in the hippocampus ZA Cope, ML Lavadia, AJM Joosen, CJA van de Cappelle, JC Lara, ... Cognitive, Affective, & Behavioral Neuroscience 20, 1173-1183, 2020 | 8 | 2020 |